By Brazil Stock Guide — The consolidation of Brazil’s private healthcare industry has produced an economic effect that goes beyond balance sheets, stock-market multiples and margin debates: large-scale job creation.
Ten listed healthcare companies have added nearly 80,000 employees since the pre-pandemic period. Based on a BTG Pactual sample, their combined workforce rose from about 166,000 employees in 2019 to roughly 245,000 in 2025, an increase of almost 48%.
The expansion was led mainly by Hapvida (HAPV3) and Rede D’Or (RDOR3), which have become the largest employers among Brazil’s listed healthcare companies. Hapvida increased its workforce from about 49,700 employees in 2019 to 77,700 in 2025, a net addition of roughly 28,000 people. Rede D’Or went from 57,600 to 82,400 employees over the same period, adding about 24,800 jobs.
Together, the two companies accounted for more than 50,000 of the nearly 80,000 net jobs added by the sample since 2019.
The numbers show how private healthcare has become one of Brazil’s major platforms for formal employment in the post-pandemic economy. The sector gained scale, became more vertically integrated, tapped the capital markets and went through a wave of mergers and acquisitions that reshaped the industry’s competitive structure.
Hapvida merged with NotreDame Intermédica in one of the largest corporate combinations ever seen in Brazil’s healthcare sector. Rede D’Or expanded through hospital acquisitions and also incorporated health insurer SulAmérica, broadening its reach beyond its traditional hospital business. Oncoclínicas (ONCO3) grew through a series of acquisitions of clinics, physicians’ groups and regional operations. Mater Dei (MATD3), Blau (BLAU3), Viveo (VVEO3) and Oncoclínicas itself gained visibility during the decade’s IPO cycle.
That combination of IPOs, market capital, consolidation and M&A created larger companies — and companies that are also far more labor-intensive. Human capital and technology remain two of the most critical inputs in healthcare.
The expansion, however, was not evenly distributed.
Fleury (FLRY3) added about 7,500 employees since 2019, reaching roughly 23,000 workers in 2025. Oncoclínicas more than tripled its employee base, from about 2,000 to 7,300, reflecting a growth model based on consolidating clinics and specialized services. Mater Dei also more than doubled its headcount, from 3,100 to 7,900 employees.
Viveo, Hypera, Dasa and Blau also increased their workforces over the period, although with different weights in the overall picture. In Dasa’s case, the comparison requires caution, as its employee base was affected by corporate reorganizations and the transfer of hospital assets to Rede Américas.
Qualicorp (QUAL3) is the main outlier. The company, which also pursued acquisitions and consolidation moves in the past, ended 2025 with fewer employees than it had in 2019. Its workforce fell from about 2,000 to 1,200 people, a net reduction of roughly 700 jobs.
The broader economic reading is that Brazil’s private healthcare consolidation story was not only about shareholders, valuations and asset integration. It also created large national employers across hospitals, clinics, health plans, laboratories, pharmaceuticals, distribution and specialized services.
At the same time, the data help explain why healthcare remains a complex sector for investors. The same labor intensity that supports job creation also makes cost management more sensitive. Hospitals, health insurers, laboratories and clinics depend on people, scale and daily execution. Growing in healthcare almost always means hiring more workers, integrating different cultures and pursuing productivity in highly complex operations.
The result is one of the clearest signs of the sector’s structural transformation: listed private healthcare companies emerged from the pandemic larger, more consolidated and with a far bigger workforce than they had before Covid.
For an industry often analyzed through margins, medical-loss ratios, leverage and valuation, the employment data highlight a more positive side of the story. The consolidation of Brazil’s private healthcare sector has also become a macroeconomic story — one of capital, scale, formalization and job creation.
Leave a Reply